Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
|Active Ingredient:||Laronidase 0.58mg/mL|
|Dosage Form:||Concentrate for infusion|
|New Zealand Sponsor:||Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics|
|Manufacturer:||Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany|
Dated this 13th day of June 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).